Pharmaceutical

VMS OneVoice Named Best Patient/Consumer Education Program by PM360 Magazine Trailblazer

INDIANAPOLIS, Oct. 8, 2024 /PRNewswire/ -- VMS BioMarketing announced today it was honored as a finalist in the PM360 Trailblazer Awards…

1 year ago

WCG Releases 2024 Report on Top Issues Impacting Clinical Research Sites

PRINCETON, N.J., Oct. 8, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve the quality and…

1 year ago

Ubie, Inc. adds Google as an investor in its latest funding round

NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Ubie Inc. is pleased to announce that it has received investment from Google in…

1 year ago

Petauri™ Announces Formation of Petauri Advance

Rapidly growing pharmaceutical services provider unites existing capabilities into a comprehensive Medical Communications platform NASHVILLE, Tenn., Oct. 8, 2024 /PRNewswire/…

1 year ago

Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium

Axtria showcases its collaboration with leading pharma companies on AI-driven insights, field force optimization, and data strategies. CHICAGO, Oct. 8,…

1 year ago

MellingMedical Expands Its Suite of Ophthalmological Offerings with Iantrek’s Cutting Edge Solutions

Offering broad array of medical products essential to veteran care ALEXANDRIA, Va., Oct. 8, 2024 /PRNewswire/ -- MellingMedical is pleased to announce…

1 year ago

Optimum Strategic Communications to Host 16th Annual Healthcare Investor Conference with ‘Back to Growth’ theme

LONDON, Oct. 8, 2024 /PRNewswire/ -- Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 16th Annual…

1 year ago

Lexaria Updates Current GLP-1 Market

KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a…

1 year ago

CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC

Live webcast fireside chat on Wednesday, October 16th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / October 8, 2024…

1 year ago

Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial

SAN FRANCISCO, CA / ACCESSWIRE / October 8, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") today announced that a late-breaking abstract…

1 year ago